对氨基水杨酸及其多种盐类在人体中的生物利用度IV：四种品牌钠盐的比较。 - Suppr

Suppr

超能文献

Bioavailability of aminosalicylic acid and its various salts in humans IV: comparison of four brands of the sodium salt.

作者信息

Pentikäinen P J, Wan S H, Azarnoff D L

出版信息

J Pharm Sci. 1974 Sep;63(9):1431-4. doi: 10.1002/jps.2600630921.

DOI:10.1002/jps.2600630921

PMID:4610119

Abstract

摘要

相似文献

Bioavailability of aminosalicylic acid and its various salts in humans IV: comparison of four brands of the sodium salt.对氨基水杨酸及其多种盐类在人体中的生物利用度IV：四种品牌钠盐的比较。

J Pharm Sci. 1974 Sep;63(9):1431-4. doi: 10.1002/jps.2600630921.

Bioavailability studies on p-aminosalicylic acid and its various salts in man. II. Comparison of parasal and pascorbic.对人进行的对氨基水杨酸及其各种盐类的生物利用度研究。II. 对氨柳酸和抗坏血酸的比较。

Am Rev Respir Dis. 1973 Dec;108(6):1340-70. doi: 10.1164/arrd.1973.108.6.1340.

Importance of the type of dosage form and saturable acetylation in determining the bioactivity of p-aminosalicylic acid.剂型类型和饱和乙酰化作用在确定对氨基水杨酸生物活性方面的重要性。

Am Rev Respir Dis. 1973 Sep;108(3):536-46. doi: 10.1164/arrd.1973.108.3.536.

Bioavailability of aminosalicylic acid and its various salts in humans. 3. Absorption from tablets.氨基水杨酸及其各种盐类在人体中的生物利用度。3. 片剂的吸收情况。

J Pharm Sci. 1974 May;63(5):708-11. doi: 10.1002/jps.2600630512.

[The level of p-aminosalicyclic acid in the blood in oral treatment with a calcium-aluminum-p-aminosalicylate].[口服钙铝对氨基水杨酸盐治疗时血液中对氨基水杨酸的水平]

Ned Tijdschr Geneeskd. 1968 Sep 14;112(37):1630-4.

Effect of food coadministration on 5-aminosalicylic acid oral suspension bioavailability.食物共同给药对5-氨基水杨酸口服混悬液生物利用度的影响。

Clin Pharmacol Ther. 1990 Jul;48(1):26-33. doi: 10.1038/clpt.1990.113.

[Metabolism of PASA during administration of the preparation once and thrice daily].[制剂每日给药一次和三次期间PASA的代谢情况]

Probl Tuberk. 1967;45(4):70-4.

The role of the metabolism of p-aminosalicylic acid (PAS) in the treatment of tuberculosis. Interaction with the metabolism of isonicotinic acid hydrazide (INH) and the synthesis of cholesterol.对氨基水杨酸（PAS）代谢在结核病治疗中的作用。与异烟肼（INH）代谢及胆固醇合成的相互作用。

Scand J Respir Dis. 1969;50(3):169-85.

[Studies on the metabolism of para-aminosalicylic acid in the body. IV. Effect of sodium salt of para-animosalicylic acid administered orally in coated tablets soluble in the intestine on the bacteriostatic level and on drug tolerance].[对氨基水杨酸在体内的代谢研究。IV. 口服肠道可溶包衣片中对氨基水杨酸的钠盐对抑菌水平和药物耐受性的影响]

Gruzlica. 1967 Jul;35(7):657-64.

5-aminosalicylic acid in a slow-release preparation: bioavailability, plasma level, and excretion in humans.缓释制剂中的5-氨基水杨酸：人体生物利用度、血药浓度及排泄情况

Gastroenterology. 1982 Nov;83(5):1062-70.

引用本文的文献

New and Repurposed Drugs for the Treatment of Active Tuberculosis: An Update for Clinicians.新型和再利用药物治疗活动性结核病：临床医生的最新进展。

Respiration. 2023;102(2):83-100. doi: 10.1159/000528274. Epub 2022 Dec 14.

The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intolerance.对氨基水杨酸的药代动力学及其与疗效和不耐受性的关系。

Br J Clin Pharmacol. 2020 Nov;86(11):2123-2132. doi: 10.1111/bcp.14395. Epub 2020 Jun 21.

HPLC analysis of para-aminosalicylic acid and its metabolite in plasma, cerebrospinal fluid and brain tissues.高效液相色谱法分析血浆、脑脊液和脑组织中对氨基水杨酸及其代谢物。

J Pharm Biomed Anal. 2011 Apr 5;54(5):1101-9. doi: 10.1016/j.jpba.2010.11.031. Epub 2010 Nov 27.

Clinical pharmacokinetics of the antituberculosis drugs.抗结核药物的临床药代动力学。

Clin Pharmacokinet. 1984 Nov-Dec;9(6):511-44. doi: 10.2165/00003088-198409060-00003.

Quantitation of hepatic and pulmonary first-pass effects and its implications in pharmacokinetic study. I. Pharmacokinetics of chloroform in man.

J Pharmacokinet Biopharm. 1975 Jun;3(3):193-201. doi: 10.1007/BF01067908.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验